References
ADVERSE EVENT
Trial protocolClick here for additional data file.eMethods 1. Trial design, Oversight, Investigational Medicinal Product and RandomisationeTable 1. PARABLE Inclusion and Exclusion CriteriaeFigure 1. Design of the PARABLE trialeMethods 2. Medication Titration ProtocoleTable 2. Study Titration ScheduleeMethods 3. Description of Study AssessmentseTable 3. Overview of Study AssessmentseMethods 4. Detailed Description of Sample Size Calculations and Statistical MethodseTable 4. Detailed Cardiometabolic Medications at BaselineeTable 5. Detailed Cardiometabolic Medications at Follow upeTable 6. Additional Biochemistry at BaselineeTable 7. Additional Biochemistry at Follow UpeFigure 2. Change in per-protocol maximal left atrial volume index using cardiac MRIeFigure 3. Time to first serious adverse cardiovascular eventeTable 8. Serious Adverse Event (SAE) over the study data by System-Organ-ClassClick here for additional data file.Data sharing statementClick here for additional data file.